8 July, 2021, by ClinCaptureUser
ClinCapture is excited to announce additional features in Captivate® 3.7. The latest release is available to current and new customers. It includes enhancements to medical coding, secure data deletion, and enhancements to change reports.
Medical Coding Support for CTCAE 5.0 Oncology
Captivate® Coder has been updated to support the latest version of the Common Terminology Criteria for Adverse Events (CTCAE). Customers running oncology studies have access to the most recent adverse event data when using our medical coding module.
Secure Data Deletion Option
Captivate® EDC is validated and allows our customers to be fully FDA 21 CFR Part 11 compliant, ensuring data integrity and security. We’ve added additional options for user management which allow for greater flexibility in user regulation.
Enhancements to Change Reports
Change reports in Captivate® allow you to see exactly what’s being promoted from your test environment to a secondary study. We’ve added a summary cover page to change reports to make it easier to identify which studies the report was generated for and when the change report was generated.
To learn more about our latest release or to upgrade your study, please contact your ClinCapture account manager.
Up Next
-
Read more +10 July, 2024
Liquid Biopsy: The Future of Non-Invasive Cancer Diagnostics
Liquid Biopsy: The Future of Non-Invasive Cancer Diagnostics Liquid biopsy is an innovative and increasingly influential method in cancer diagnostics, offering significant advantages over traditional tissue biopsy by detecting cancer information through a simple blood sample. This non-invasive technique allows for the detection of circulating tumor DNA (ctDNA), circulating tumo -
Read more +11 June, 2024
Genomics in Cancer Diagnosis and Prognosis and the Role of Electronic Data Capture (EDC) Systems
Genomics in Cancer Diagnosis and Prognosis and the Role of Electronic Data Capture (EDC) Systems The integration of genomics into the field of oncology has ushered in a transformative era in cancer care, enhancing both diagnosis and prognosis by allowing clinicians to understand the genetic basis of cancers more deeply. This shift towards a genomics-driven approach enables more -
Read more +29 May, 2024
Emerging Trends in Precision Medicine: Integrating Epigenetics into Oncology
Trends in Precision Medicine: Integrating Epigenetics into Oncology Precision medicine in oncology is continually evolving, with recent advances in epigenetics presenting new pathways for understanding and treating cancer more effectively. Epigenetics involves the study of heritable changes in gene expression that do not involve alterations to the underlying DNA sequence — es